Plasma triglyceride, cholesterol and low-density lipoprotein (LDL) cholesterol values and the urinary albumin/creatinine ratio in the everolimus (EVR) group (n = 35 until month 24 and n = 33 at month 36 and 48) and in the control group (n = 70).
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Plasma_triglyceride_cholesterol_and_low_density_lipoprotein_LDL_cholesterol_values_and_the_urinary_albumin_creatinine_ratio_in_the_everolimus_EVR_group_n_35_until_month_24_and_n_33_at_month_36_and_48_and_in_the_control_group_n_70_/1556514
下载链接
链接失效反馈官方服务：
资源简介：
Month 1: Values determined before initiation of EVR therapy.
P values were calculated by the two-sample t-test.
Plasma triglyceride, cholesterol and low-density lipoprotein (LDL) cholesterol values and the urinary albumin/creatinine ratio in the everolimus (EVR) group (n = 35 until month 24 and n = 33 at month 36 and 48) and in the control group (n = 70).
创建时间：
2015-09-25
